The $800 million pill : the truth behind the cost of new drugs / / Merrill Goozner

• Autore: Goozner Merrill <1950->
• Pubblicazione: Berkeley : , : University of California Press, , 2004; ©2004
• Edizione: 1st ed.
• Descrizione fisica: 1 online resource (304 pages)
• Disciplina: 338.4/3/61510973
• Soggetto topico: Prescription pricing; Drugs - Prices; Pharmaceutical industry; Consumer education
• Soggetto non controllato: american society; biochemists; biotech drugs; drug companies; drug cost; drug culture; drug funding; drug innovation; drug manufacturing; drug pricing; expose piece; genetic disorders; government funded research; high costs; human genome project; investments; medical breakthroughs; medical innovations; medical research; pharmaceutical companies; prescription drugs; private sector; public heath; public sector; research and development; us government
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: Front matter -- Contents -- Introduction -- PART ONE. BIOHYPE -- PART TWO. DIRECTED RESEARCH -- PART THREE. BIG PHARMA -- Notes -- Bibliography -- Acknowledgments -- Index
• Sommario/riassunto: Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The
• Altri titoli varianti: Eight hundred million dollar pill
• Titolo autorizzato: The
• ISBN: 1-282-35824-3; 9786612358241; 0-520-93928-X; 1-59734-450-8
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910814843603321
• Lo trovi qui: Univ. Federico II